Table 2.
The number of monocyte subsets in T-NHL patients and the health control.
| control | T-NHL | P value | |
|---|---|---|---|
| Sex (male:female) | 17:14 | 17:14 | |
| Age | 42.5 | 43.9 | |
| Monocyte (X109) | 0.43 ± 0.10 | 0.52 ± 0.31 | 0.125 |
| Monocyte (%) | 6.58 ± 0.98 | 8.28 ± 4.21 | 0.036 |
| CD16− monocyte (X109) | 0.41 ± 0.09 | 0.48 ± 0.29 | 0.229 |
| CD16− monocyte (%) | 6.30 ± 0.96 | 7.53 ± 3.86 | 0.096 |
| CD16 + monocyte (X109) | 0.018 ± 0.006 | 0.044 ± 0.033 | <0.001 |
| CD16 + monocyte (%) | 0.28 ± 0.07 | 0.75 ± 0.5 | <0.001 |
| CD16− monocyte/D16 + monocyte | 24.44 ± 8.12 | 12.97 ± 8.11 | <0.001 |